Exciting Breakthrough in CAR-T Cell Therapy Offers New Hope for Solid Tumor Treatment. In a groundbreaking study that could revolutionize cancer treatment, researchers have unveiled a new CAR-T cell...
In an exciting development in the field of cancer immunotherapy, researchers have engineered a new dual-target CAR T-cell therapy that simultaneously targets two key antigens, CD19 and CD20, in...
Image by Erin_Hinterland/pixabay A groundbreaking study has delved into the potential interactions between cannabidiol (CBD) and CD19-chimeric antigen receptor (CAR) T cell therapy, a promising approach in cancer immunotherapy....
Image by Herney/pixabay In a notable advancement in cell engineering research, scientists have developed the first ligand-based, piggyBac-transfected anti-EGFR CAR-T cells, targeting non-small cell lung cancer (NSCLC). NSCLC often...
The researchers from Chulalongkorn University developed an effective way to grow cytokine-induced killer (CIK) cells using a gas-permeable culture method. This method allowed them to produce a large number...
CAR T-cell therapy is a new treatment for certain types of blood cancer that involves genetically engineering T cells to target cancer cells. The therapy involves growing and expanding...
Scientists from Chulalongkorn University are studying a new treatment for breast cancer called CAR T-cell therapy. They have created CAR T-cells that target a specific antigen called mucin-1 (MUC1)...
A team of researchers from Chulalongkorn University has developed a highly efficient hybridoma generation and screening strategy to generate high-potency chimeric anti-PD-1 molecules, a protein that plays a significant...